The Fanconi anaemia/BRCA pathway

Cited by (823)

Items 501–600 of 823

1. FANCD2 Expression in Advanced Non–Small-Cell Lung Cancer and Response to Platinum-Based Chemotherapy
   Miriam Ferrer, Simone W. Span, Barbara Vischioni, Joost J. Oudejans, P. J. van Diest, Johan P. de Winter, Giuseppe Giaccone, Frank A.E. Kruyt · 2005 · Clinical Lung Cancer
2. Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes
   In Sil Choi, Hye Seung Lee, Keun‐Wook Lee, Haeryoung Kim, Ki Hwan Kim, Yu Jung Kim, Jee Hyun Kim, Woo Ho Kim, Jong Seok Lee · 2010 · Medical Oncology
3. Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets
   Jurgen A. F. Marteijn, Joop H. Jansen, Bert A. van der Reijden · 2006 · Leukemia
4. Advances in the understanding of the Fanconi anemia tumor suppressor pathway
   Anna Pickering, Jun Zhang, Jayabal Panneerselvam, Peiwen Fei · 2013 · Cancer Biology & Therapy
5. TonEBP Regulates PCNA Polyubiquitination in Response to DNA Damage through Interaction with SHPRH and USP1
   Hyun Je Kang, Hyun Park, Eun Jin Yoo, Jun Ho Lee, Soo Youn Choi, Whaseon Lee‐Kwon, Kyoo‐young Lee, Jin‐Hoe Hur, Jeong Kon Seo, Jae Sun Ra et al. · 2019 · iScience
6. Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.
   Chinnadurai Mani, Kaushlendra K. Tripathi, Sandeep Chaudhary, Ranganatha R. Somasagara, Rodney Paul Rocconi, Chiquito J. Crasto, Mark B. Reedy, Mohammad Athar, Komaraiah Palle · 2021 · Neoplasia
7. Analysis of a FANCE Splice Isoform in Regard to DNA Repair
   Frédérick Bouffard, Karine V. Plourde, Simon Bélanger, Geneviève Ouellette, Yvan Labrie, Francine Durocher · 2015 · Journal of Molecular Biology
8. Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival
   Riom Kwakman, Erienne M.V. de Cuba, Johan P. de Winter, Ignace H. J. T. de Hingh, Pien M. Delis‐van Diemen, Marianne Tijssen, Martin A. Rooimans, Oscar Krijgsman, Beatriz G. Carvalho, Godefridus J. Peters et al. · 2015 · British Journal of Cancer
9. The antitumor agent doxorubicin binds to Fanconi anemia group F protein
   Tomoe Kusayanagi, Senko Tsukuda, Satomi Shimura, Daisuke Manita, Kanako Iwakiri, Shinji Kamisuki, Yoichi Takakusagi, Toshifumi Takeuchi, Kouji Kuramochi, Atsuo Nakazaki et al. · 2012 · Bioorganic & Medicinal Chemistry
10. FANCD2 depletion sensitizes cancer cells repopulation ability in vitro
    Alex Lyakhovich, Jordi Surrallés · 2007 · Cancer Letters
11. FANCJ Expression Predicts the Response to 5-Fluorouracil-Based Chemotherapy in MLH1-Proficient Colorectal Cancer
    Ryota Nakanishi, Hiroyuki Kitao, Yoshihiko Fujinaka, Nami Yamashita, Makoto Iimori, Eriko Tokunaga, Natsumi Yamashita, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara · 2012 · Annals of Surgical Oncology
12. Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients
    Laura Spugnesi, Michele Gabriele, Rosa Scarpitta, Mariella Tancredi, Luisa Maresca, Gaetana Gambino, Anita Collavoli, Paolo Aretini, Ilaria Bertolini, B. Salvadori et al. · 2016 · Genes Chromosomes and Cancer
13. Breast cancer genetic susceptibility: With focus in Saudi Arabia
    Fawaz Dabea Alshammari · 2019 · Journal of Oncological Sciences
14. High-Throughput Screening Identifies Novel Agents Eliciting Hypersensitivity in Fanconi Pathway–Deficient Cancer Cells
    Eike Gallmeier, Tomáš Hucl, Jonathan Robert Brody, David A. Dezentjé, Khola S. Tahir, Jana Kašpárková, Viktor Brabec, Kurtis E. Bachman, Scott E. Kern · 2007 · Cancer Research
15. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes
    Graça A. Justo, Marco Antonio Bitencourt, Ricardo Pasqüini, Morgana Teixeira Lima Castelo-Branco, Aline Almeida-Oliveira, Hilda Rachel Diamond, Vivian Mary Rumjanek · 2013 · Annals of Hematology
16. INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells
    Ying Hao Sun, Huan Ding, Xinguang Liu, Xiaoqing Li, Li Li · 2014 · Tumor Biology
17. Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
    Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Leo Petzer, Sonja Burgstaller, David Fuchs, Dieter H. Rossmann, Marija Balić, Daniel Egle, Holger F. Rumpold, Christian Fridolin Singer et al. · 2018 · BMC Cancer
18. Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia
    Nils W. Engel, Simon Schliffke, Ulrich Schüller, Christian Frenzel, Carsten Bokemeyer, Christian Kubisch, Davor Lessel · 2019 · Frontiers in Oncology
19. p53 null Fluorescent Yellow Direct Repeat (FYDR) mice have normal levels of homologous recombination
    Dominika M. Wiktor‐Brown, Michelle R. Sukup-Jackson, Saja A. Fakhraldeen, Carrie A. Hendricks, Bevin P. Engelward · 2011 · DNA repair
20. Targeting DNA damage and repair by curcumin.
    Zhenyu Ji · 2010 · PubMed Central
21. Double-strand breaks and the concept of short- and long-term epigenetic memory
    Christian Orlowski, Li-Jeen Mah, Raja S. Vasireddy, Assam El‐Osta, Tom C. Karagiannis · 2010 · Chromosoma
22. Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
    Verena L. Bauer, Ludwig Hieber, Quirin Schaeffner, Johannes Weber, Herbert Braselmann, Reinhard Huber, Axel Karl Walch, Horst F. Zitzelsberger · 2010 · Genes
23. Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway
    Seok-Won Jang, Jin Ki Jung, Jung Min Kim · 2016 · Cell Cycle
24. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: Activation is not required for repair of Cr(VI)-induced DSBs
    Susan K. Vilcheck, Susan M. Ceryak, Travis J. O’Brien, Steven R. Patierno · 2006 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
25. DNA repair in human fibroblasts, as reflected by host-cell reactivation of a transfected UV-irradiated luciferase gene, is not related to donor age
    Thomas J. Merkle, Katherine O’Brien, Philip John Brooks, Robert E. Tarone, Jay H. Robbins · 2004 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
26. Oxidative Stress-Associated Protein Tyrosine Kinases and Phosphatases in Fanconi Anemia
    Jie Li, Qishen Pang · 2013 · Antioxidants and Redox Signaling
27. Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
    Volha Dudaladava, Michał Jarząb, Ewa Stobiecka, Ewa Chmielik, Krzysztof Simek, Tomasz Huzarski, Jan Lubiński, Jolanta Pamuła‐Piłat, Wioletta Pękala, Ewa Anna Grzybowska et al. · 2006 · Hereditary Cancer in Clinical Practice
28. Potential of Human Induced Pluripotent Stem Cells Derived from Blood and Other Postnatal Cell Types
    Zhaohui Ye, Linzhao Cheng · 2010 · Regenerative Medicine
29. DNA Damage Response Pathways and Cancer
    James M. Ford, Michael B. Kastan · 2014 · Elsevier eBooks
30. Upregulated ATM Gene Expression and Activated DNA Crosslink-Induced Damage Response Checkpoint in Fanconi Anemia: Implications for Carcinogenesis
    Kazuhiko Yamamoto, Abdallah Nihrane, Jason A. Aglipay, Juan Sironi, Steven Arkin, Jeffrey Michael M Lipton, Toru Ouchi, Johnson M. Liu · 2008 · Molecular Medicine
31. Centrosome amplification and aneuploidy in bone marrow failure patients
    William G. Kearns, Hiroki Yamaguchi, Neal S. Young, Johnson M. Liu · 2004 · Genes Chromosomes and Cancer
32. A genomic copy number signature predicts radiation exposure in post‐ C hernobyl breast cancer
    Christina Wilke, Herbert Braselmann, Julia Heß, Sergiy V. Klymenko, Vadim V. Chumak, Л. М. Захарцева, Elena V. Bakhanova, Axel Karl Walch, Martin Selmansberger, Daniel Samaga et al. · 2018 · International Journal of Cancer
33. Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study
    Pedro Luiz Serrano Usón, Katie L. Kunze, Michael A. Golafshar, Gehan Botrus, Douglas L. Riegert‐Johnson, L. Boardman, Mitesh J. Borad, Daniel H. Ahn, Mohamad Bassam Sonbol, Allon Kahn et al. · 2022 · Digestive Diseases and Sciences
34. Four decades of DNA repair: from early insights to current perspectives
    Philip C. Hanawalt · 2003 · Biochimie
35. ATP-dependent nucleosome unwrapping catalyzed by human RAD51
    Justin A. North, Ravindra Amunugama, Marcelina Klajner, Aaron N. Bruns, Michael Guy Poirier, Richard A. Fishel · 2013 · Nucleic Acids Research
36. Cisplatin and the sensitive cell
    Grover C. Bagby, Susan B. Olson · 2003 · Nature Medicine
37. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production
    Ilgın Çağnan, Ayşen GÜNEL ÖZCAN, Fatima Aerts‐Kaya, Najim Ameziane, Barış Kuşkonmaz, Josephine C. Dorsman, Fatma Gümrük, Duygu Uçkan · 2017 · Stem Cell Reviews and Reports
38. Applications of Fluorescence for Detecting Rare Sequence Rearrangements In Vivo
    Dominika M. Wiktor‐Brown, Carrie A. Hendricks, Werner Olipitz, Arlin B. Rogers, Bevin P. Engelward · 2006 · Cell Cycle
39. Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment
    JN Bulmer, Natalie Zacal, Andrew J. Rainbow · 2005 · Cancer Chemotherapy and Pharmacology
40. BRCA2 Function and the Central Nervous System
    Pierre‐Olivier Frappart, Peter J. McKinnon · 2007 · Cell Cycle
41. Genetic Susceptibility to Iatrogenic Malignancy
    James M. Allan, Charles S. Rabkin · 2005 · Pharmacogenomics
42. L’anémie de Fanconi : gènes et fonction(s) revisités
    Dora Papadopoulo, Ethel Moustacchi · 2005 · médecine/sciences
43. Large deletion causing von Hippel-Lindau disease and hereditary breast cancer syndrome
    Karol Krzystolik, Anna Jakubowska, Jacek Gronwald, Maciej Robert Krawczynski, Monika Drobek-Słowik, Leszek Michał Sagan, Leszek Cyryłowski, Wojciech Lubiński, Jan Lubiński, Cezary Cybulski · 2014 · Hereditary Cancer in Clinical Practice
44. A novel role for the deubiquitinase USP1 in the control of centrosome duplication
    Jin Ki Jung, Seok-Won Jang, Jung Min Kim · 2016 · Cell Cycle
45. BRCA mutations in pancreatic cancer and progress in their targeting
    Samer Alkassis, Omid Yazdanpanah, Philip Agop Philip · 2021 · Expert Opinion on Therapeutic Targets
46. Evolutionary genomics of human intellectual disability
    Bernard J. Crespi, Kyle Summers, Steve Dorus · 2009 · Evolutionary Applications
47. Transcription coupled repair deficiency protects against human mutagenesis and carcinogenesis
    James E. Cleaver · 2017 · DNA repair
48. DNA Double-Strand Break Damage and Repair Assessed by Pulsed-Field Gel Electrophoresis
    Nina Joshi, Stephen G. Grant · 2004 · Humana Press eBooks
49. Non-homologous End-Joining Defect in Fanconi Anemia Hematopoietic Cells Exposed to Ionizing Radiation
    José Antonio Casado, Marı́a Isabel Núñez, Jose Carlos Segovia, José Mariano Ruiz de Almodóvar, Juan Antonio Bueren · 2005 · Radiation Research
50. Repair of DNA interstrand crosslinks may take place at the nuclear matrix
    Boyko S. Atanassov, Anastas G. Gospodinov, Ivaylo Stoimenov, Emil Mladenov, George Ch. Russev, Irina R. Tsaneva, Boyka Anachkova · 2005 · Journal of Cellular Biochemistry
51. Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer
    Yawei Li, Zhangxiang Zhao, Liqiang Ai, Yuquan Wang, Kaidong Liu, Bo Chen, Tingting Chen, Shuping Zhuang, Huanhuan Xu, Min Zou et al. · 2021 · iScience
52. Evolution of Pre-Existing versus Acquired Resistance to Platinum Drugs and PARP Inhibitors in BRCA-Associated Cancers
    Kimiyo N. Yamamoto, Kouji Hirota, Shunichi Takeda, Hiroshi Haeno · 2014 · PLoS ONE
53. Prédisposition héréditaire au cancer du sein (1)
    Odile Cohen‐Haguenauer · 2019 · médecine/sciences
54. Brca2 deficiency drives gastrointestinal tumor formation and is selectively inhibited by mitomycin C
    Xiaomin Chen, Fangfei Peng, Yan Ji, Honggang Xiang, Xiang Wang, Tingting Liu, Heng Wang, Yumin Han, Changxu Wang, Yongfeng Zhang et al. · 2020 · Cell Death and Disease
55. Fanconi anemia
    Alan D. D’Andrea · 2003 · Current Biology
56. The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer
    Sanna‐Maria Karppinen · 2009
57. Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?
    Monika Martha Engelhardt, Gabriele Ihorst, Jo Caers, Andreas Günther, Ralph Wäsch · 2016 · Haematologica
58. Differential roles for Chk1 and FANCD2 in ATR-mediated signalling for psoralen photoactivation-induced senescence
    Miriam Große Hovest, Thomas M. Krieg, Gernot Herrmann · 2011 · Experimental Dermatology
59. Assembling an orchestra: Fanconi anemia pathway of repair
    Fenghua Yuan · 2010 · Frontiers in bioscience
60. Multiple Endocrine Neoplasia Type 1 with Unusual Concomitance of Various Neoplastic Disorders
    Yoshihiro Nishimura, Koh Yamashita, Wataru Yumita, Masanori Yamazaki, Miyuki Katai, Akihiro Sakurai, Kiyoshi Hashizume · 2004 · Endocrine Journal
61. Prostate cancer in the era of “Omic” medicine: recognizing the importance of DNA damage repair pathways
    Zachary Kornberg, Jonathan Chou, Felix Yi-Chung Feng, Charles J. Ryan · 2018 · Annals of Translational Medicine
62. A common environmental carcinogen unduly affects carriers of cancer mutations: Carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen
    Bernard Friedenson · 2011 · Medical Hypotheses
63. Enhancement of Nitric Oxide Release in Mouse Inflammatory Macrophages Co-cultivated with Tumor Cells of a Different Origin
    Lido Calorini, Francesca Bianchini, Antonella Mannini, Gabriele Mugnai, Salvatore Ruggieri · 2005 · Clinical & Experimental Metastasis
64. MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair
    Lorri R. Marek, Molly C. Kottemann, Peter M. Glazer, Allen E. Bale · 2008 · DNA repair
65. Systems Biology-Based Identification of Crosstalk between E2F Transcription Factors and the Fanconi Anemia Pathway
    Moe Tategu, Takako Arauchi, Rena Tanaka, Hiroki Nakagawa, Kenichi Yoshida · 2007 · Gene Regulation and Systems Biology
66. Characterization of the hamster FancG/Xrcc9 gene and mutations in CHO UV40 and NM3
    Jane E. Lamerdin · 2004 · Mutagenesis
67. Repression of DNA Repair Mechanisms in IRF-4-Expressing and HTLV-I-Infected T Lymphocytes
    Yaël Mamane, Martin Loignon, Jennifer Palmer, Eduardo Hernandez, Raymond Césaire, Moulay A. Alaoui‐Jamali, John B. Hiscott · 2005 · Journal of Interferon & Cytokine Research
68. Impairment of homologous recombination control in a Fanconi anemia‐like Chinese Hamster Cell mutant
    Florence Larminat, Maryse Germanier, Efterpi Papouli, Martine J. Defais · 2004 · Biology of the Cell
69. Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer
    Cristina Nieto‐Jiménez, Ana Lucía Alcaraz-Sanabria, Sandra Martínez‐Canales, Verónica Corrales‐Sánchez, Juan Carlos Montero, Miguel Burgos, Miriam Nuncia‐Cantarero, Atanasio Pandiella, Eva María Galán‐Moya, Alberto Ocaña · 2020 · International Journal of Molecular Sciences
70. Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines
    Antonella Muscella, Luca Giulio Cossa, Erika Stefàno, Gianluca Rovito, Michele Benedetti, Francesco Paolo Fanizzi, Santo Marsigliante · 2024 · International Journal of Molecular Sciences
71. Human KIAA1018/FAN1 nuclease is a new mitotic substrate of APC/CCdh1
    Fenju Lai, Kaishun Hu, Yuanzhong Wu, Jianjun Tang, Yi Sang, Jingying Cao, Tiebang Kang · 2012 · 癌症：英文版
72. Identification of small‐molecule binding sites of a ubiquitin‐conjugating enzyme‐ UBE2T through fragment‐based screening
    Yong Yao Loh, Jothi Anantharajan, Qiwei Huang, Weijun Xu, Justina Fulwood, Hui Qi Ng, Elizabeth Yihui Ng, Chong Yu Gea, Meng Ling Choong, Qian Wen Tan et al. · 2024 · Protein Science
73. Fanconi anaemia in black South African patients heterozygous for the FANCG c.637-643delTACCGCC founder mutation
    Tasha Wainstein, Robyn A. Kerr, Claire L Mitchell, Smita Madaree, Fahmida Essop, Elana Vorster, Rosalind Wainwright, Janet Poole, Amanda Krause · 2013 · South African Medical Journal
74. Biochemical Activities and Genetic Functions of the Drosophila melanogaster Fancm Helicase in DNA Repair
    Noelle-Erin Romero, Steven W. Matson, Jeff J. Sekelsky · 2016 · Genetics
75. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients
    Ilgın Çağnan, Mustafa Keleş, Ayşe Gökçe Keşküş, Melike Tombaz, Özge Burcu Şahan, Fatima Aerts‐Kaya, Duygu Uçkan, Özlen Konu, Ayşen GÜNEL ÖZCAN · 2021 · Human Cell
76. DNA Damage Response Pathways and Cancer
    James M. Ford, Michael B. Kastan · 2020 · Elsevier eBooks
77. A Comparative Analysis of Immunorestoration and Recovery with Conventional and Immunotherapeutic Protocols in Canine Generalized Demodicosis: A Newer Insight of Immunotherapeutic Efficacy of T11TS
    P. Sarkar, Joydeep Mukherjee, A. Ghosh, M. Bhattacharjee, S. Mahato, A. Chakraborty, Madhumita Mondal, C. Banerjee, Swapna Chaudhuri · 2004 · Immunological Investigations
78. Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis
    Mateusz Koptyra, Tomasz Stokłosa, Grażyna Hoser, Eliza Głodkowska‐Mrówka, Ilona Seferyńska, Agata Klejman, Janusz Błasiak, Tomasz Skórski · 2011 · Leukemia
79. Inflammation and Immunity
    Francesco Boin, Carlo Chizzolini · 2016 · Springer eBooks
80. Inherited Bone Marrow Failure Syndromes
    Lorraine E. Canham, Jill L. O. de Jong · 2024 · Elsevier eBooks
81. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia
    Stefan Meyer, Lisa M. Barber, Daniel J. White, AJ Will, Jillian M. Birch, Janice Kohler, Klaus Ersfeld, Eric Blom, Hans Joenje, Tim O.B. Eden et al. · 2006 · British Journal of Haematology
82. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells
    Angela Filograna, Stefano De Tito, Matteo Lo Monte, Rosario Oliva, Francesca Bruzzese, Maria Serena Roca, Antonella Zannetti, Adelaide Greco, Daniela Spano, Inmaculada Ayala et al. · 2024 · Journal of Experimental & Clinical Cancer Research
83. DNA-protein cross-links emerge as major contributors to chemotherapeutic cytotoxicity at physiological equitoxic doses
    Mahmoud I. Shoulkamy, Tareg Omer Mohammed, Hiroshi Ide, Toshiaki Nakano · 2025 · Scientific Reports
84. Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
    Sarah J Taylor, Mark Johan Arends, Simon P. Langdon · 2020 · Exploration of Targeted Anti-tumor Therapy
85. Defective cell proliferation is an attribute of overexpressed Notch1 receptor and impaired autophagy in Fanconi Anemia
    Binita E. Zipporah, Bamadeb Patra, Kavitha Govarthanan, Rajesh Kumar Yadav, Sheila Mohan, Pavithra Shyamsunder, Rama Shanker Verma · 2020 · Genomics
86. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells
    Lin Zhao, Yanlin Li, Miao He, Zhiguo J. Song, Shu Lin, Zhaojin Yu, Xuefeng Bai, NHUA WANG, Minjie Wei · 2014 · International Journal of Oncology · Retracted
87. Fanconi Anemia Pathway Genes Advance Cervical Cancer via Immune Regulation and Cell Adhesion
    Shizhi Wang, Bo Ding, Mengjing Cui, Wenjing Yan, Qianqian Xia, Dan Meng, Siyuan Shen, Shuqian Xie, Hua Jin, Xing Zhang · 2021 · Frontiers in Cell and Developmental Biology
88. Expression of FANCD2 in sporadic breast cancer and clinicopathological analysis
    Bo Zhang, Ru Chen, Jianhua Lu, Qinfang Shi, Xue Zhang, Jianying Chen · 2010 · Journal of Huazhong University of Science and Technology [Medical Sciences]
89. Regulation of Fanconi anemia protein FANCD2 monoubiquitination by miR-302
    Bharathi Suresh, Arumugam Madhan Kumar, Hoe-Su Jeong, Youl-Hee Cho, Suresh Ramakrishna, Kye-Seong Kim · 2015 · Biochemical and Biophysical Research Communications
90. Cell Cycle Control of Germ Cell Differentiation
    Cassy M. Spiller, Peter A. Koopman · 2011 · Results and problems in cell differentiation
91. BRCA1 and BRCA2 in Breast Cancer Predisposition and Recombination Control
    Ralph Scully, Anyong Xie · 2004 · Journal of Mammary Gland Biology and Neoplasia
92. Update on childhood neutropenia: molecular and clinical advances
    Yigal Dror, Lillian Sung · 2004 · Hematology/Oncology Clinics of North America
93. Impaired removal of DNA interstrand cross‐link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA‐defective group
    Ken Tsuchida, Kenshi Komatsu · 2008 · Cancer Science
94. Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers
    Yoo‐Kyung Lee, Noh-Hyun Park, Hyun‐Sook Lee · 2015 · Experimental & Molecular Medicine
95. Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer
    Nalo M. Hamilton, Diana C. Márquez‐Garbán, Vei H. Mah, Yahya Elshimali, David A. Elashoff, Edward B. Garon, Jaydutt V. Vadgama, Richard J. Pietras · 2015 · Critical Reviews™ in Oncogenesis
96. Disruption of the fanconi anemia pathway in human cancer in the general population
    Céline F. Jacquemont, Toshi Taniguchi · 2006 · Cancer Biology & Therapy
97. Correction of mutant Fanconi anemia gene by homologous recombination in human hematopoietic cells using adeno‐associated virus vector
    Kittiphong Paiboonsukwong, Fumi Ohbayashi, Haruka Shiiba, Emi Aizawa, Takayuki Yamashita, Kohnosuke Mitani · 2009 · The Journal of Gene Medicine
98. The RPA inhibitor HAMNO sensitizes Fanconi anemia pathway-deficient cells
    Seok-Won Jang, Jung Min Kim · 2022 · Cell Cycle
99. Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCC
    Yang Li, Muzhapaer Maimaiti, Bowen Yang, Zeyi Lu, Qiming Zheng, Yudong Lin, Wenqin Luo, Ruyue Wang, Lifeng Ding, Huan Wang et al. · 2023 · Cellular Signalling
100. FANCL, as in ligase
     Markus Grompe · 2003 · Nature Genetics